Identifying patients with ischaemic heart disease in general practice: cross sectional study of paper and computerised medical records
- 2 September 2000
- Vol. 321 (7260) , 548-550
- https://doi.org/10.1136/bmj.321.7260.548
Abstract
Objectives: To identify patients with ischaemic heart disease by using a practice computer and to estimate the work required to do so. Design: Cross sectional study. Data from the notes and from the computer records of 1680 patients were used to build a database. This was used to compare different methods of identifying patients with ischaemic heart disease. Setting: 11 general practices in the Battersea primary care group in south London. Subjects: 1 in 40 random sample of patients aged 45 or older. Main outcome measures: Numbers of patients identified with ischaemic heart disease. Results: The combination of the Read code for ischaemic heart disease (G3) and a prescription for a nitrate had a 73% sensitivity and a yield (100/positive predictive value) of one case of ischaemic heart disease for every 1.2 sets of notes reviewed. By searching the records of patients also receiving aspirin, atenolol, digoxin, or a statin, the sensitivity was increased to 96% but the yield fell to one in three. Conclusion: Although commonly used to identify cases, a computer search for G3 code or nitrate missed almost 30% of patients with ischaemic heart disease. A substantially higher percentage of patients can be identified by adding other drugs to the search strategy.Keywords
This publication has 6 references indexed in Scilit:
- An assessment of morbidity registers for coronary heart disease in primary care. ASSIST (ASSessment of Implementation STrategy) trial collaborative group.2000
- Management of ischaemic heart disease in primary care: towards better practiceJournal of Public Health, 1999
- Aspirin use in middle-aged men with cardiovascular disease: are opportunities being missed?1997
- A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).Heart, 1996
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)The Lancet, 1994
- Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of diseaseThe Lancet, 1994